Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2003
11/13/2003CA2484963A1 7-hydroxy-16a-fluoro-5-androsten-17-ones and 7-hydroxy-16a-fluoro-5-androstan-17-ones and derivatives thereof
11/13/2003CA2484874A1 Monocompartment osmotic controlled drug delivery system
11/13/2003CA2484797A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484258A1 Soya cell strains with high isoflavone content
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators
11/13/2003CA2483927A1 Treatment of diabetes and diabetic complications with nhe-1 inhibitors
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483633A1 Composition and method for reducing post-prandial blood glucose
11/13/2003CA2481322A1 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
11/12/2003EP1361264A1 PRODUCTS CONTAINING $G(b)-GLUCAN
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1360964A1 Use of galanin-like peptide
11/12/2003EP1360960A1 Use of ketoconazole and related substances in medicaments for treatment of type II diabetes
11/12/2003EP1360957A1 Vitamin/mineral complex
11/12/2003EP1360508A2 Prediction of wound healing by urinary nitrate assay
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360199A2 Treatment involving dkk-1 or antagonists thereof
11/12/2003EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP1360169A2 Succinate salt of o-desmethyl-venlafaxine
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1359931A1 Prevention of diabetes by administration of gnrh antagonists
11/12/2003EP1359926A1 AN ANTI-DIABETIC AGENT OBTAINED FROM THE PLANT $i(HUMBOLDTIA DECURRENS) AND A PROCESS FOR PREPARING THE SAME
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP1233973B1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
11/12/2003EP1216057B1 Stable calcitriol solution for packaging in vials
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1133308B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
11/12/2003EP0991618B1 Selective thyroid hormone analogs
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455778A Tartrate salt of thiazolidinedione derivative
11/12/2003CN1455777A Tartrate salts of thiazolidinedione derivative
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1455675A Anti-glycuresis preparation obtained from plant Humboldtia decurrens and preparation method thereof
11/12/2003CN1455670A Combination of lipoic acids and conjugated acids for treating diabetic disorders
11/12/2003CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
11/12/2003CN1455666A Externally-applicated chewing gum including chip-like center
11/12/2003CN1455662A Dental care compositions
11/12/2003CN1454900A Glucose and insulin response element
11/12/2003CN1454598A Compound phytosterol with serum cholesterol-reducing action and preparing process thereof
11/12/2003CN1454588A Polypeptide protein oral nano particle preparation
11/12/2003CN1454513A Extraction of water soluble organic calcium from egg shell of birds and preparation of two-calcium nutrient intensifying liguor
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127502C Salts of paroxetine
11/12/2003CN1127497C Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
11/12/2003CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors
11/12/2003CN1127349C Antilipemic slimming tea preparation
11/12/2003CN1127344C Oral pill for treating diabetes and its complication
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
11/11/2003US6645985 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them, and method of treating
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645751 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/11/2003US6645533 ATP synthesis activator containing a mixture of herbs
11/06/2003WO2003091728A1 Screening method
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091282A1 Histamine receptor h3 ordinary activity mutant and utilization thereof
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091250A1 [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents
11/06/2003WO2003091239A1 Estrogen receptor modulators
11/06/2003WO2003091236A1 Imidazolinylmethyl aralkylsulfonamides
11/06/2003WO2003091234A1 Biguanide derivative and therapeutic agent for diabetes containing the same
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003091216A1 Novel piperidine derivative
1 ... 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 ... 1298